Solid Tumors Harboring NTRK Fusion Completed Phase Trials for Larotrectinib (DB14723)

Also known as: Solid Tumors Harbouring NTRK Fusion / Solid Tumors Habouring NTRK Fusion

DBCOND0117977 (Solid Tumors Harboring NTRK Fusion)CompletedNot Available IdentifierTitlePurposeDrugs
NCT05192642A Study Called VICTORIA to Learn More About How Well Larotrectinib Works in Adults With TRK Fusion-positive Cancer by Comparing Larotrectinib Data From Clinical Studies With Data of Other Treatments From Actual Practice